Dr. Lisa M. Coussens received $7.1 million in Komen funding...
Lisa M. Coussens, Ph.D., Hildegard Lamfrom Chair in Basic Science, Professor and Chair of
the OHSU Department of Cell & Developmental Biology, Associate Director of Basic Research for the OHSU Knight Cancer Institute, along with two other collaborators, are the recipients of a Promise Grant, Komen’s largest and most prestigious honor. Komen grants are dedicated to the rapid translation of scientific discoveries into new or enhanced treatments with the highest potential to reduce breast cancer incidence or mortality.
Dr. Coussens received $7.1 million in Komen funding. In addition to her Komen Promise Grant of $6.5 million, she received and additional grant for $600,000.
With Dr. Coussen’s grants, Komen’s funding to OHSU has exceeded the $10 million in support of crucial breast cancer research. These and other projects further Komen’s mission to save lives and end breast cancer forever. This cumulative commitment represents Komen’s single largest investment in Oregon.
Komen’s Research Program plays an essential role in energizing science to pursue new treatments and potential cures.
Dr. Coussens (center) is pictured above with her lab staff of post-doctoral fellows.